5-hydroxymethylcytosine has been researched along with Glioma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, F; Hu, X; Liu, Y; Mao, Q; Xia, L; Xie, D; Yan, X; Yan, Z; Yin, S; Yuan, Y; Zhang, J; Zhang, S | 1 |
| Aldape, K; Farooq, H; Glowacka, WK; Jain, H; Kongkham, P; Maimaitiming, A; Mamatjan, Y; Nejad, R; Okura, M; Taylor, MD | 1 |
| Ding, Y; Fu, R; Guo, SW; Huang, KM; Li, DS; Luo, J; Tang, XJ | 1 |
| Astudillo, A; Bayón, GF; Belmonte, T; Bonilla, F; Carella, A; Cobo, I; Cueto Díaz, S; Domínguez, G; Fernandez, AF; Ferrero, C; Fraga, MF; García Alonso, JI; García, MG; López, V; Mangas, C; Meléndez, B; Menendez, P; Mollejo, M; Ortea, I; Pérez, RF; Rodrigo, L; Rodríguez-Gonzalez, P; Santamarina, P; Sierra, MI; Tejedor, JR; Toraño, EG; Urdinguio, RG | 1 |
| Krais, AM; Meister, M; Park, YJ; Plass, C; Reifenberger, G; Schmeiser, HH | 1 |
| Ahsan, S; Ballester, LY; Eberhart, CG; Haffner, MC; Nazarian, J; Quezado, M; Raabe, EH; Rodriguez, FJ; Vaghasia, A; Warren, KE | 1 |
| Cui, Y; Freeman, JL; Irudayaraj, J; Li, J; Liu, J; Liu, Q; Weng, L; Wirbisky, SE; Yuan, X | 1 |
| Frye, S; Guan, KL; Ito, S; Jiang, WQ; Kim, SH; Lei, QY; Liu, J; Liu, LX; Liu, Y; Wang, B; Wang, P; Xiao, MT; Xiong, Y; Xu, W; Xu, YH; Yang, C; Yang, H; Yang, Y; Zhang, JY; Zhang, Y; Zhao, SM | 1 |
| Becker, A; Denkhaus, D; Freihoff, D; Freihoff, J; Gessi, M; Hammes, J; Isselstein, LJ; Luxen, D; Müller, T; Pietsch, T; Simon, M; Waha, A; zur Mühlen, A | 1 |
| Eberhart, CG; Haffner, MC; Nelson, WG; Orr, BA; Yegnasubramanian, S | 1 |
10 other study(ies) available for 5-hydroxymethylcytosine and Glioma
| Article | Year |
|---|---|
Noninvasive detection of brain gliomas using plasma cell-free DNA 5-hydroxymethylcytosine sequencing.
Topics: 5-Methylcytosine; Brain; Brain Neoplasms; Glioma; Humans; Isocitrate Dehydrogenase; Mutation | 2023 |
5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma.
Topics: 5-Methylcytosine; Adult; Aged; Brain Neoplasms; Cohort Studies; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Neoplasm Grading; RNA, Messenger; Up-Regulation | 2018 |
Ten-eleven translocation 1 regulates methylation of autophagy-related genes in human glioma.
Topics: 5-Methylcytosine; Autophagy; Brain; Brain Neoplasms; Cell Line, Tumor; DNA Methylation; Glioma; Humans; Mixed Function Oxygenases; Neoplasm Grading; Proto-Oncogene Proteins | 2018 |
Loss of 5hmC identifies a new type of aberrant DNA hypermethylation in glioma.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Case-Control Studies; CpG Islands; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genome, Human; Glioma; Humans | 2018 |
Sensitive detection of hydroxymethylcytosine levels in normal and neoplastic cells and tissues.
Topics: 5-Methylcytosine; Animals; Cell Dedifferentiation; DNA Methylation; Electrophoresis, Capillary; Fluorescence; Glioma; Humans; Lung Neoplasms; Mice; Neoplasms | 2019 |
Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma.
Topics: 5-Methylcytosine; Age Factors; Brain Stem Neoplasms; Child; Child, Preschool; Cytosine; DNA Methylation; Epigenomics; Female; Gene Expression Regulation, Neoplastic; Glioma; Humans; Male; Statistics, Nonparametric; Tissue Array Analysis | 2014 |
Regulatory landscape and clinical implication of MBD3 in human malignant glioma.
Topics: 5-Methylcytosine; Brain Neoplasms; Cell Line, Tumor; Disease-Free Survival; DNA-Binding Proteins; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; High-Throughput Nucleotide Sequencing; HLA-D Antigens; Humans; MicroRNAs; Oligonucleotide Array Sequence Analysis; Pilot Projects; RNA Interference; RNA, Long Noncoding; RNA, Untranslated; Signal Transduction; Time Factors; Transcription, Genetic; Transfection | 2016 |
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.
Topics: 5-Methylcytosine; Amino Acid Substitution; Animals; Binding, Competitive; Biocatalysis; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Catalytic Domain; Cell Line, Tumor; Cytosine; Dioxygenases; DNA-Binding Proteins; Endostatins; F-Box Proteins; Gene Expression; Glioma; Glutarates; Histone Demethylases; Histones; Homeodomain Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Isocitrate Dehydrogenase; Jumonji Domain-Containing Histone Demethylases; Ketoglutaric Acids; Mixed Function Oxygenases; Models, Molecular; Oxalates; Oxidoreductases, N-Demethylating; Procollagen-Proline Dioxygenase; Proto-Oncogene Proteins | 2011 |
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.
Topics: 5-Methylcytosine; Brain Neoplasms; Cell Line, Tumor; Cell Nucleus; Cytosine; Dioxygenases; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; DNA-Binding Proteins; Dual-Specificity Phosphatases; Female; Gene Expression Regulation, Enzymologic; Glioblastoma; Glioma; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Male; Mitogen-Activated Protein Kinase Phosphatases; Mixed Function Oxygenases; Mutation; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction; RNA, Messenger; Sequence Analysis, DNA; Subcellular Fractions; Tumor Suppressor Proteins | 2012 |
Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma.
Topics: 5-Methylcytosine; Brain; Cell Differentiation; Cytosine; Glioma; Humans; Immunohistochemistry; Neurons; Stem Cells | 2012 |